Tempest Therapeutics, Inc.
(NASDAQ : MLND)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.06%171.110.7%$969.22m
ABBVAbbVie, Inc. 0.24%138.371.9%$829.97m
PFEPfizer Inc. 0.39%49.460.9%$828.27m
LLYEli Lilly & Co. -0.25%300.551.1%$744.28m
MRKMerck & Co., Inc. 0.01%87.420.7%$739.97m
BMYBristol-Myers Squibb Co. 0.14%72.221.0%$650.72m
SIGASIGA Technologies, Inc. 4.41%24.330.0%$431.11m
AZNAstraZeneca Plc -0.21%65.891.0%$380.66m
ALNYAlnylam Pharmaceuticals, Inc. 1.48%221.818.1%$244.83m
GSKGSK Plc 0.10%40.610.3%$218.07m
HZNPHorizon Therapeutics Plc 0.34%69.845.4%$198.47m
SGENSeagen Inc. 1.39%178.255.7%$191.36m
NVSNovartis AG 0.61%86.090.2%$174.44m
RGENRepligen Corp. 0.86%248.396.7%$157.09m
NVONovo Nordisk A/S -0.55%102.630.1%$152.05m

Company Profile

Tempest Therapeutics, Inc.is a clinical-stage biotechnology company. It develops small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. The company is headquartered in South San Francisco, CA.